OPEN ACCESS pISSN 2234-3806
eISSN 2234-3814

Cited by CrossRef (21)

  1. Hossein Ayatollahi, Arezoo Shajiei, Mohammad Hadi Sadeghian, Maryam Sheikhi, Ehsan Yazdandoust, Masumeh Ghazanfarpour, Seyyede Fatemeh Shams, Sepideh Shakeri. Prognostic Importance of C-KIT Mutations in Core Binding Factor Acute Myeloid Leukemia. 2017;10:1
    https://doi.org/10.1016/j.hemonc.2016.08.005
  2. Huimin Jin, Yu Zhu, Ming Hong, Yujie Wu, Hairong Qiu, Rong Wang, Hui Jin, Qian Sun, Jianxin Fu, Jianyong Li, Sixuan Qian, Chun Qiao. Co-occurrence of KIT and NRAS mutations defines an adverse prognostic core-binding factor acute myeloid leukemia. Leukemia & Lymphoma 2021;62:2428
    https://doi.org/10.1080/10428194.2021.1919660
  3. Magdy Elbordiny, Reham AboElwafa, Abeer Elhadidi, Ashraf Elghandour, Salma Elmasry. Molecular profiling of acute myeloid leukemia with Runx1-Runx1t1 fusion. Alexandria Journal of Medicine 2024;60:282
    https://doi.org/10.1080/20905068.2024.2387881
  4. Mateusz Pospiech, Mukund Tamizharasan, Yu-Chun Wei, Advaith Maya Sanjeev Kumar, Mimi Lou, Joshua Milstein, Houda Alachkar. Features of the TCR repertoire associate with patients' clinical and molecular characteristics in acute myeloid leukemia. Front. Immunol. 2023;14
    https://doi.org/10.3389/fimmu.2023.1236514
  5. Sergio Pina-Oviedo, Haitham A. Khogeer, Guilin Tang, Roberto N. Miranda. Oncological Surgical Pathology. 2023.
    https://doi.org/10.1007/978-3-319-96681-6_17
  6. Passant Badr, Ghada M Elsayed, Dalia Negm Eldin, Bahia Y Riad, Nayera Hamdy. Detection of KIT mutations in core binding factor acute myeloid leukemia. Leukemia Research Reports 2018;10:20
    https://doi.org/10.1016/j.lrr.2018.06.004
  7. Rodica P. Bunaciu, Robert J. MacDonald, Feng Gao, Lynn M. Johnson, Jeffrey D. Varner, Xin Wang, Sarah Nataraj, Monica L. Guzman, Andrew Yen. Potential for subsets of wt-NPM1 primary AML blasts to respond to retinoic acid treatment. Oncotarget 2018;9:4134
    https://doi.org/10.18632/oncotarget.23642
  8. Shyam Srinivasan, Shathish Kumar, Kalasekhar Vijayasekharan, Amit Kumar Agrawal. Prevalence and Clinical Outcome of FMS-Like Tyrosine Kinase Mutations Among Patients With Core Binding Factor—Acute Myeloid Leukemia: Systematic Review and Meta-Analysis. Clinical Lymphoma Myeloma and Leukemia 2022;22:e221
    https://doi.org/10.1016/j.clml.2021.09.020
  9. I De Kouchkovsky, M Abdul-Hay. ‘Acute myeloid leukemia: a comprehensive review and 2016 update’. Blood Cancer Journal 2016;6:e441
    https://doi.org/10.1038/bcj.2016.50
  10. Min Yang, Bide Zhao, Jinghan Wang, Yi Zhang, Chao Hu, Lixia Liu, Jiayue Qin, Feng Lou, Shanbo Cao, Chengcheng Wang, Wenjuan Yu, Hongyan Tong, Haitao Meng, Jian Huang, Honghu Zhu, Jie Jin. A Predictor Combining Clinical and Genetic Factors for AML1-ETO Leukemia Patients. Front. Oncol. 2022;11
    https://doi.org/10.3389/fonc.2021.783114
  11. Katherine Tarlock, Todd A. Alonzo, Yi-Cheng Wang, Robert B. Gerbing, Rhonda Ries, Michael R. Loken, Laura Pardo, Tiffany Hylkema, Jason Joaquin, Leela Sarukkai, Susana C. Raimondi, Betsy Hirsch, Lillian Sung, Richard Aplenc, Irwin Bernstein, Alan S. Gamis, Soheil Meshinchi, Jessica A. Pollard. Functional Properties of KIT Mutations Are Associated with Differential Clinical Outcomes and Response to Targeted Therapeutics in CBF Acute Myeloid Leukemia. 2019;25:5038
    https://doi.org/10.1158/1078-0432.CCR-18-1897
  12. Nikolai Nikolaevich Mamaev, Ya.V. Gudozhnikova, A.V. Gorbunova. WT1 Gene Overexpression in Oncohematological Disorders: Theoretical and Clinical Aspects (Literature Review). Клиническая онкогематология 2016;9:257
    https://doi.org/10.21320/2500-2139-2016-9-3-257-264
  13. Xi Chen, Hu Dou, Xingjuan Wang, Yi Huang, Ling Lu, Junqing Bin, Yongchun Su, Lin Zou, Jie Yu, Liming Bao. KITmutations correlate with adverse survival in children with core-binding factor acute myeloid leukemia. Leukemia & Lymphoma 2018;59:829
    https://doi.org/10.1080/10428194.2017.1361025
  14. Ja Min Byun, Young Jin Kim, Hwi-Joong Yoon, Si-Young Kim, Hee-Je Kim, Jaeho Yoon, Yoo Hong Min, Jun-Won Cheong, Jinny Park, Jae Hoon Lee, Dae Sik Hong, Seong Kyu Park, Hyeoung-Joon Kim, Jae-Sook Ahn, Ho-Jin Shin, Joo Seop Chung, Won Sik Lee, Sang Min Lee, Yong Park, Byung Soo Kim, Je-Hwan Lee, Kyoo-Hyung Lee, Chul Won Jung, Jun Ho Jang, Woo-Sung Min, Tae Sung Park. Cytogenetic profiles of 2806 patients with acute myeloid leukemia—a retrospective multicenter nationwide study. Ann Hematol 2016;95:1223
    https://doi.org/10.1007/s00277-016-2691-1
  15. Xiong‐yu Liao, Jian‐pei Fang, Dun‐hua Zhou, Kun‐yin Qiu. CEBPA are independent good prognostic factors in pediatric acute myeloid leukemia. Hematological Oncology 2022;40:258
    https://doi.org/10.1002/hon.2951
  16. Wei Qin, Xiayu Chen, Hong Jie Shen, Zheng Wang, Xiaohui Cai, Naike Jiang, Haiying Hua. Comprehensive mutation profile in acute myeloid leukemia patients with RUNX1- RUNX1T1 or CBFB-MYH11 fusions. Tjh 2022
    https://doi.org/10.4274/tjh.galenos.2022.2021.0641
  17. Annalisa Talami, Francesca Bettelli, Valeria Pioli, Davide Giusti, Andrea Gilioli, Corrado Colasante, Laura Galassi, Rachele Giubbolini, Hillary Catellani, Francesca Donatelli, Rossana Maffei, Silvia Martinelli, Patrizia Barozzi, Leonardo Potenza, Roberto Marasca, Tommaso Trenti, Enrico Tagliafico, Patrizia Comoli, Mario Luppi, Fabio Forghieri. How to Improve Prognostication in Acute Myeloid Leukemia with CBFB-MYH11 Fusion Transcript: Focus on the Role of Molecular Measurable Residual Disease (MRD) Monitoring. Biomedicines 2021;9:953
    https://doi.org/10.3390/biomedicines9080953
  18. Davide Leardini, Daria Messelodi, Edoardo Muratore, Francesco Baccelli, Salvatore N. Bertuccio, Laura Anselmi, Andrea Pession, Riccardo Masetti. Role of CBL Mutations in Cancer and Non-Malignant Phenotype. Cancers 2022;14:839
    https://doi.org/10.3390/cancers14030839
  19. Yamei Zhai, Qingya Wang, Li Ji, Hanyun Ren, Yujun Dong, Fan Yang, Yue Yin, Zeyin Liang, Qian Wang, Wei Liu, Yan Mei, Lu Zhang, Yuan Li. Clinical characteristics and prognostic factors analysis of core binding factor acute myeloid leukemia in real world. Cancer Medicine 2023;12:21592
    https://doi.org/10.1002/cam4.6693
  20. Bo Lei, Yinxia Chen, Aili He, Jing Luo, Pengyu Zhang, Fuling Zhou, Jie Liu, Xin Meng, Jing Wang, Wanggang Zhang. C59T mutation in exon 2 of monocytic leukemia-associated antigen-34 gene indicates a high risk of recurrence of acute myeloid leukemia. 2017;14:55
    https://doi.org/10.3892/ol.2017.6110
  21. Mahdiyar Iravani Saadi, Javad Moayedi, Fakhroddin Hosseini, Hossain Ali Rostamipour, Zahed Karimi, Zahra Rahimian, Maryam Ahmadyan, Zahra Ghahramani, Mehdi Dehghani, Karim Yousefi, Nadiya Kheradmand, Mani Ramzi, Nastaran Fooladivanda. The Effects of Resveratrol, Gallic Acid, and Piperine on the Expression of miR-17, miR-92b, miR-181a, miR-222, BAX, BCL-2, MCL-1, WT1, c-Kit, and CEBPA in Human Acute Myeloid Leukemia Cells and Their Roles in Apoptosis. Biochem Genet 2024;62:2958
    https://doi.org/10.1007/s10528-023-10582-8
© Korean Society for Laboratory Medicine. / Powered by INFOrang Co., Ltd